Mynomin Tablet SR
Marketer
Olwen Lifesciences Private Limited
Salt Composition
Metformin (500mg) + Myo-Inositol (600mg)
Overview Mynomin Tablet SR
Mynovin Extended-Release tablets combine two medications to manage polycystic ovary syndrome (PCOS). This treatment helps regulate ovulation and menstrual cycles in women with PCOS, improves insulin sensitivity, and balances hormones for better overall well-being. Always follow your doctor's instructions for dosage and frequency; take with food, ideally at the same time daily. If you miss a dose, take it promptly unless your next dose is imminent; never double the dose. Potential side effects include altered taste, nausea, diarrhea, vomiting, abdominal discomfort, and decreased appetite. These are typically transient and self-limiting, but persistent symptoms warrant medical attention. Before starting Mynovin ER, disclose any kidney, liver, or heart conditions, and pregnant or breastfeeding individuals should seek medical counsel. Pre-treatment kidney function tests are standard. Limit alcohol consumption while using this medication to minimize potential side effects.
Primary Ingredients of Mynomin Tablet SR
No text was provided to rewrite.
Uses of Mynomin Tablet SR
Managing Polycystic Ovary Syndrome (PCOS)
Major Benefits of Mynomin Tablet SR:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Mynomin Tablet SR with a meal.
Common Side effects of Mynomin Tablet SR:
- Taste change
- Dizziness
- Stomach pain
- Nausea
- Diarrhea
- Loss of appetite
How to use Mynomin Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for Mynomin Tablet SR. Ingest the tablet whole; do not chew, crush, or divide it. Administer this medication with a meal.
How Mynomin Tablet SR works:
Mynomin SR tablets contain a dual-medication formulation.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol use with Mynomin Tablet SR is contraindicated.
PregnancyCONSULT YOUR DOCTOR
Data on Mynomin Tablet SR use in pregnancy is absent. Seek medical advice from your physician.
Breast feedingCONSULT YOUR DOCTOR
Data on the compatibility of Mynomin Tablet SR with breastfeeding are unavailable. Seek medical advice from your physician.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Exercise caution when prescribing Mynomin Tablet SR to individuals with impaired renal function; dosage modification may be necessary. Consult a physician before administering. Mynomin Tablet SR is contraindicated in patients exhibiting severe kidney disease. Routine monitoring of kidney function is recommended during treatment.
LiverCAUTION
Patients with liver impairment should exercise caution when using Mynomin Tablet SR. Dosage modification may be necessary, and physician consultation is advised. For those with mild to moderate liver disease, a low initial dose of Mynomin Tablet SR is typically recommended; however, its use is contraindicated in patients with severe hepatic dysfunction.
What if you forget to take Mynomin Tablet SR :
Should you forget to take a Mynomin Tablet SR, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Mynomin Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently